NTRC Competitors and Similar CompaniesClear all
Nektar Therapeutics's competitors and similar companies include Candel Therapeutics.
 Candel Therapeutics Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies. | ||
Founding Date | Founding Date 1990 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Needham, US HQ |
Employees | Employees 61821% increase | Employees 50 |
Valuation ($) | Valuation ($) 233.8 m | Valuation ($) 176.8 m |
Financial | ||
Net income | Net income ($164.1m) (FY, 2025) | Net income ($38.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 45m | Total funding raised $ 64.6m |
For sources of this data, please see the company profile
View Company Profiles
Candel Therapeutics
HQ
Needham, US
Employees
50
Candel Therapeutics (formerly known as Advantagene) is a biopharmaceutical company developing cancer immunotherapies.
View company